Semaglutide (also known as GLP-1 receptor agonist) is a GLP-1 receptor agonist approved for type 2 diabetes and weight management. This page covers what the published research does — and does not — establish about it in relation to fat loss and weight management.
Semaglutide is researched for Appetite & weight management, Cardiometabolic health — which is why it appears in discussions of fat loss and weight management.
Research status: FDA-approved with large-scale human clinical trials.
How Semaglutide is thought to work
Semaglutide is a GLP-1 receptor agonist that mimics an incretin hormone released after eating. It slows gastric emptying, increases satiety, and improves insulin response — mechanisms that underpin its FDA-approved use in type 2 diabetes and chronic weight management.
What it does not establish
Prescription medication with known side effects. Use only under medical supervision.
Nothing on this page is a recommendation to use Semaglutide, and Selpho publishes no dosing, reconstitution or sourcing information. Read how we decide what goes in the library.
Other peptides researched for Fat Loss
A dual GIP/GLP-1 receptor agonist approved for diabetes and weight management.
An investigational triple GIP/GLP-1/glucagon agonist studied for weight loss.
A long-acting amylin analog studied for appetite and weight, often with semaglutide.
An investigational GLP-1/glucagon dual agonist studied for weight and liver health.
Frequently asked questions
FDA-approved with large-scale human clinical trials. Research relevant to this area covers appetite & weight management, cardiometabolic health. That is a description of where the research points, not evidence that it will work for you — and Selpho does not provide dosing or medical advice.
FDA-approved with large-scale human clinical trials.
Prescription medication with known side effects. Use only under medical supervision. Always speak to a licensed healthcare professional before considering any peptide.
It is FDA-approved for type 2 diabetes and for chronic weight management, backed by large-scale human clinical trials.
Primarily by reducing appetite and slowing stomach emptying, which lowers calorie intake, alongside effects on blood-sugar regulation.
Is Semaglutide right for your situation?
Describe your goals and the free Peptide Advisor will match them against the research — no signup, no sales pitch.
Ask the Advisor — freeThis page is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.